Biotech News

Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio

Tactile Systems Technology, Inc. (TCMD)Tactile Systems Technology, Inc.Company update

LymphaTech’s 3D Platform and Digital Capabilities to Improve Disease Identification, Accelerate Therapy Adoption, and Support Next-Generation Lymphatic Therapies MINNEAPOLIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a

Related news

Tactile Systems Technology, Inc.

At-Home Chronic-Care Therapies Tactile Medical develops and markets at-home therapies for underserved chronic conditions. Its products help patients manage long-term diseases outside hospitals and clinics while supporting clinician-directed treatment plans. Lymphedema Portfolio The company's Flexitouch systems deliver pneumatic...

Recent company news

Stock data

Close
23.82 USD
Market cap
550.6M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States